Cargando…

Curcumin-induced promoter hypermethylation of the mammalian target of rapamycin gene in multiple myeloma cells

Curcumin, a polyphenol derived from the rhizome of Curcuma, is a potential tumor inhibitor through affecting signaling pathways and epigenetic regulation. The mammalian target of rapamycin (mTOR) gene serves a crucial role in the carcinogenesis of multiple myeloma. The curcumin-induced epigenetic re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jiaqi, Ying, Yongli, Zhu, Hongjun, Zhu, Tingjun, Qu, Chunsheng, Jiang, Jinhong, Fang, Bingmu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312997/ https://www.ncbi.nlm.nih.gov/pubmed/30655872 http://dx.doi.org/10.3892/ol.2018.9662

Ejemplares similares

Combining the mammalian target of rapamycin inhibitor, rapamycin, with resveratrol has a synergistic effect in multiple myeloma
por: Jin, Hong-Guang, et al.
Publicado: (2018)

Clinicopathological significance of p15 promoter hypermethylation in multiple myeloma: a meta-analysis
por: Wei, Bing, et al.
Publicado: (2016)

Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers
por: Agirre, Xabier, et al.
Publicado: (2015)

Comprehensive elaboration of circular RNA in multiple myeloma
por: Zhu, Chunsheng, et al.
Publicado: (2022)

What are the roles of global DNA and APC 2 gene promotor hypermethylation in multiple myeloma?
por: Pehlivan, Sacide, et al.
Publicado: (2021)

P01.15. Multiple Myeloma, chemotherapy and curcumin
por: Panutich, E, et al.
Publicado: (2012)

Rheb and mammalian target of rapamycin in mitochondrial homoeostasis
por: Groenewoud, Marlous J., et al.
Publicado: (2013)

Clinicopathological significance of the p16 hypermethylation in multiple myeloma, a systematic review and meta-analysis
por: Yu, Huiqing, et al.
Publicado: (2017)

Mechanistic/mammalian target of rapamycin and side effects of antipsychotics: insights into mechanisms and implications for therapy
por: Zhuo, Chuanjun, et al.
Publicado: (2022)

Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy
por: Ramakrishna, Rajeev, et al.
Publicado: (2020)

Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer
por: Xu, Da-zhi, et al.
Publicado: (2010)

Inhibition of mammalian target of rapamycin by rapamycin increases the radiosensitivity of esophageal carcinoma Eca109 cells
por: ZHANG, DEJUN, et al.
Publicado: (2014)

The BCMA-Targeted Fourth-Generation CAR-T Cells Secreting IL-7 and CCL19 for Therapy of Refractory/Recurrent Multiple Myeloma
por: Duan, Deming, et al.
Publicado: (2021)

Hypermethylation of the Promoter Region of miR-23 Enhances the Metastasis and Proliferation of Multiple Myeloma Cells via the Aberrant Expression of uPA
por: Ran, Qijie, et al.
Publicado: (2022)

Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis
por: Kim, Won Seop
Publicado: (2011)

SIRT1 Negatively Regulates the Mammalian Target of Rapamycin
por: Ghosh, Hiyaa Singhee, et al.
Publicado: (2010)

Mammalian target of rapamycin signaling in diabetic cardiovascular disease
por: Chong, Zhao Zhong, et al.
Publicado: (2012)

Driving neural regeneration through the mammalian target of rapamycin
por: Maiese, Kenneth
Publicado: (2014)

Therapeutic control of leishmaniasis by inhibitors of the mammalian target of rapamycin
por: Khadir, Fatemeh, et al.
Publicado: (2018)

Autism Spectrum Disorder and Mammalian Target of Rapamycin System
por: Posar, Annio, et al.
Publicado: (2020)

Crosstalk of the Caspase Family and Mammalian Target of Rapamycin Signaling
por: Yan, Junfang, et al.
Publicado: (2021)

A case report of hereditary spherocytosis with concomitant chronic myelocytic leukemia
por: Xiaoqiu, Wang, et al.
Publicado: (2016)

Rapamycin protects against aristolochic acid nephropathy in mice by potentiating mammalian target of rapamycin-mediated autophagy
por: Lin, Fan, et al.
Publicado: (2021)

Regulation of Human Trophoblast GLUT3 Glucose Transporter by Mammalian Target of Rapamycin Signaling
por: Xu, Jie, et al.
Publicado: (2015)

Mammalian Tribbles Homologs at the Crossroads of Endoplasmic Reticulum Stress and Mammalian Target of Rapamycin Pathways
por: Cunard, Robyn
Publicado: (2013)

Mammalian Target of Rapamycin Complex 1 Suppresses Lipolysis, Stimulates Lipogenesis, and Promotes Fat Storage
por: Chakrabarti, Partha, et al.
Publicado: (2010)

Prospects and hot spots for mammalian target of rapamycin in the field of neuroscience from 2002 to 2021
por: Li, Lijun, et al.
Publicado: (2022)

Prognostic Relevance of Promoter Hypermethylation of Multiple Genes in Breast Cancer Patients
por: Sharma, Gayatri, et al.
Publicado: (2009)

Clinical significance of DAPK promoter hypermethylation in lung cancer: a meta-analysis
por: Li, Ying, et al.
Publicado: (2015)

Mammalian target of rapamycin and head and neck squamous cell carcinoma
por: Liao, Yu-Min, et al.
Publicado: (2011)

Mammalian Target of Rapamycin: Hitting the Bull's-Eye for Neurological Disorders
por: Chong, Zhao Zhong, et al.
Publicado: (2010)

New Developments in Mammalian Target of Rapamycin Inhibitors for the Treatment of Sarcoma
por: Agulnik, Mark
Publicado: (2012)

Retraction: Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis
por: Kim, Won Seop
Publicado: (2013)

The cytotoxic T cell proteome and its shaping by mammalian Target of Rapamycin
por: Hukelmann, Jens L., et al.
Publicado: (2015)

The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling
por: Yoon, Mee-Sup
Publicado: (2017)

The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis
por: Lawrence, Jessica, et al.
Publicado: (2018)

Pathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation
por: Leal, Rita, et al.
Publicado: (2017)

Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
por: Querfurth, Henry, et al.
Publicado: (2021)

Osteopontin promotes gastric cancer progression via phosphatidylinositol-3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway
por: Qin, Yue-Chao, et al.
Publicado: (2023)

Mammalian target of rapamycin inhibition attenuates myocardial ischaemia–reperfusion injury in hypertrophic heart
por: Ma, Lei‐Lei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m1rhqkcmonfoka51rhqqmohlf5